Advertisement

Index by author

November 01, 1987; Volume 15,Issue 6

  1. Lauwers, W

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  2. Legha, S S

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  3. Lertratanangkoon, K

    1. Conversion of bromobenzene to 3-bromophenol. A route to 3- and 4-bromophenol through sulfur-series intermediates derived from the 3,4-oxide.
      K Lertratanangkoon, E C Horning and M G Horning
      Drug Metabolism and Disposition November 1987, 15 (6) 857-867;

  4. Lopez, A

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  5. Lu, K

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  6. Ludden, T M

    1. The pharmacokinetics of pentane, a by-product of lipid peroxidation.
      S R Allerheiligen, T M Ludden and R F Burk
      Drug Metabolism and Disposition November 1987, 15 (6) 794-800;

  7. Magat, W J

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  8. Malejka-giganti, D

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  9. Malet-martino, M C

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  10. Malkinson, A M

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 11) Next »
Back to top

In this issue

Advertisement